Our finding also provides plausibility for predicting the risk of tumour progression and provides additional insight for drug development and refinement of individualized treatment regimens for high‐risk NB based on MYCN and CCNB1IP1 protein interactions. Here, CCNB1IP1 is linked to neuroblastoma.